Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Notice of Intent to Publish a Funding Opportunity Announcement for Trailblazer Award for New and Early-Stage Investigators (R21 Clinical Trial Optional)

    Forecasted

    NIH will soon invite New and Early Stage Investigators to apply for the Trailblazer Award (R21) supporting innovative research that integrates engineering, physical, and biomedical sciences.

    Browse similar grants
    Early Career Research Grants for New Faculty
    OverviewSimilar Grants
    OverviewSimilar Grants

    Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

    This upcoming NIH grant will fund innovative research developing advanced bioinformatics and computational biology tools to improve biomedical data analysis and health outcomes, encouraging interdisciplinary and technology-driven projects.

    HHS-NIH11Due Mar 5, 2029$250,000

    Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

    NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.

    HHS-NIH11Forecasted Jul 31, 2027Forecasted

    Forecast to Publish a Funding Opportunity Announcement for Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

    The National Cancer Institute will soon invite applications to develop innovative, user-friendly informatics technologies that advance cancer research, spanning early tool development to initial dissemination.

    HHS-NIH11Due Oct 19, 2027$300,000

    Bioengineering Research Grants (R01 Clinical Trial Optional)

    This grant supports small multidisciplinary teams using bioengineering approaches to develop and advance innovative tools or methods for solving biomedical research or clinical problems.

    HHS-NIH11Due Jul 5, 2029$500,000

    Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

    This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.

    HHS-NIH11Forecasted Jun 4, 2027$300,000Forecasted